- Home
- SMSI vs HOTH Comparison
SMSI vs HOTH Comparison
Compare SMSI & HOTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMSI
- HOTH
- Stock Information
- Founded
- SMSI 1982
- HOTH 2017
- Country
- SMSI United States
- HOTH United States
- Employees
- SMSI N/A
- HOTH N/A
- Industry
- SMSI Computer Software: Prepackaged Software
- HOTH Biotechnology: Pharmaceutical Preparations
- Sector
- SMSI Technology
- HOTH Health Care
- Exchange
- SMSI Nasdaq
- HOTH Nasdaq
- Market Cap
- SMSI 15.3M
- HOTH 15.6M
- IPO Year
- SMSI 1995
- HOTH 2019
- Fundamental
- Price
- SMSI $0.90
- HOTH $1.60
- Analyst Decision
- SMSI Strong Buy
- HOTH Strong Buy
- Analyst Count
- SMSI 1
- HOTH 3
- Target Price
- SMSI $5.00
- HOTH $4.00
- AVG Volume (30 Days)
- SMSI 217.8K
- HOTH 1.4M
- Earning Date
- SMSI 11-12-2025
- HOTH 11-11-2025
- Dividend Yield
- SMSI N/A
- HOTH N/A
- EPS Growth
- SMSI N/A
- HOTH N/A
- EPS
- SMSI N/A
- HOTH N/A
- Revenue
- SMSI $18,658,000.00
- HOTH N/A
- Revenue This Year
- SMSI N/A
- HOTH N/A
- Revenue Next Year
- SMSI $59.48
- HOTH N/A
- P/E Ratio
- SMSI N/A
- HOTH N/A
- Revenue Growth
- SMSI N/A
- HOTH N/A
- 52 Week Low
- SMSI $0.60
- HOTH $0.65
- 52 Week High
- SMSI $1.95
- HOTH $3.80
- Technical
- Relative Strength Index (RSI)
- SMSI 62.16
- HOTH 51.02
- Support Level
- SMSI $0.71
- HOTH $1.46
- Resistance Level
- SMSI $0.82
- HOTH $1.62
- Average True Range (ATR)
- SMSI 0.04
- HOTH 0.13
- MACD
- SMSI 0.01
- HOTH -0.04
- Stochastic Oscillator
- SMSI 86.14
- HOTH 24.43
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.
About HOTH Hoth Therapeutics Inc.
Hoth Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing new-generation therapies for unmet medical needs. It is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). The company also has assets being developed for atopic dermatitis (also known as eczema) (BioLexa); a treatment for asthma and allergies using inhalational administration (HT-004); and an obesity treatment, and obesity-related diseases and conditions (HT-VA).